
Promises and limitations of nanoparticles in the era of cell therapy: Example with CD19-targeting chimeric antigen receptor (CAR)-modified T cells
Keywords: لنفوسیت بی; Nanoparticles; CD19; Chimeric antigen receptor; T cell; B cell; Cell therapy;